A Study of TAK-411 in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(20 sites)

United States

University of California San Diego, La Jolla, California

California Pacific Medical Center, San Francisco, California

UF Health Neurology - Jacksonville, Jacksonville, Florida

Visionary Investigators Network, Miami, Florida

University of South Florida, Tampa, Florida

Emory University, Atlanta, Georgia

Beth Israel Deaconess Medical Center, Boston, Massachusetts

Mayo Clinic Rochester, Rochester, Minnesota

The Curators of the University of Missouri on behalf of University of Missouri Health Care, Columbia, Missouri

The Washington University, St Louis, Missouri

Penn Blood Disorders Program - Hospital of The University of Pennsylvania, Philadelphia, Pennsylvania

Houston Methodist Research Institute, Houston, Texas

University of Washington, Seattle, Washington

Canada

University of Calgary, Calgary, Alberta

University Health Network, Toronto, Ontario

Colombia

Neuro ClinicaS.A.S, Medellín, Antioquia

Hospital Universitario San Ignacio, Bogotá, D.C.

Fundacion Valle del Lili, Cali, Valle del Cauca Department

Universidad del Rosario, Bogotá

Fundacion Oftalmologica de Santander - FOSCAL, Bucaramanga